Author:
Getz Kenneth A.,Stergiopoulos Stella,Short Mary,Surgeon Leon,Krauss Randy,Pretorius Sybrand,Desmond Julian,Dunn Derek
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference6 articles.
1. Getz K, Zuckerman R, Cropp A, Hindle A, Krauss R, Kaitin K. Measuring the incidence, causes, and repercussions of protocol amendments. Drug Inform J. 2011;45:265–275.
2. Getz KA, Kim J, Stergiopoulos S, Kaitin KI. New governance mechanisms to optimize protocol design. Therapeutic Innovation & Regulatory Science. 2013;47:651–655.
3. Scott R. Changing organizational structure, technology solutions, operating processes and practices to transform protocol design. Executive Forum, Tufts University School of Medicine; September 17, 2015.
4. Stapff M. Quality by design aspects applied to clinical study protocol development. Chimica Oggi. 2014;32:50–51.
5. Getz K, Zuckerman R, Cropp A, Hindle A, Krauss R, Kaitin K. Measuring the incidence, causes, and repercussions of protocol amendments. Drug Inform J. 2011;45:265–275.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献